Non-Hodgkin's Lymphoma, Relapsed
9 clinical trials · Condition
◉ Watch Non-Hodgkin's Lymphoma, Relapsed
| Record | Firm | Date |
|---|---|---|
| CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma (NCT05054257) | Institute of Hematology and Blood Transfusion, Czech Republic | 2021-06-02 |
| RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies (NCT04844086) | Eden BioCell Ltd. | 2021-03-02 |
| CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies (NCT04603872) | Zhejiang University | 2020-11-01 |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (NCT04030195) | Precision BioSciences, Inc. | 2020-03-24 |
| Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL (NCT00274742) | Amgen Research (Munich) GmbH | 2004-06-01 |
Track Non-Hodgkin's Lymphoma, Relapsed automatically
Every clearance here is in the API, with alerts when new ones post.